{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:55:31Z","timestamp":1790398531473,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.bone.2019.02.025","type":"journal-article","created":{"date-parts":[[2019,2,27]],"date-time":"2019-02-27T21:40:39Z","timestamp":1551303639000},"page":"231-236","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["No vascular calcification on cardiac computed tomography spanning asfotase alfa treatment for an elderly woman with hypophosphatasia"],"prefix":"10.1016","volume":"122","author":[{"given":"Michael P.","family":"Whyte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William H.","family":"McAlister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Mumm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Bierhals","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2019.02.025_bb0005","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nrendo.2016.14","article-title":"Hypophosphatasia: aetiology, nosology, pathogenesis, diagnosis and treatment","volume":"12","author":"Whyte","year":"2016","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.bone.2019.02.025_bb0010","series-title":"Chapter 28 in \u201cGenetics Of Bone Biology And Skeletal Disease\u201d","first-page":"481","article-title":"Hypophosphatasia and how alkaline phosphatase promotes mineralization","author":"Whyte","year":"2018"},{"key":"10.1016\/j.bone.2019.02.025_bb0015","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s00223-015-0079-1","article-title":"Alkaline phosphatase and hypophosphatasia","volume":"98","author":"Millan","year":"2016","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bone.2019.02.025_bb0020","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.bone.2017.02.011","article-title":"Hypophosphatasia: an overview for 2017","volume":"102","author":"Whyte","year":"2017","journal-title":"Bone"},{"key":"10.1016\/j.bone.2019.02.025_bb0025","author":"Mornet"},{"key":"10.1016\/j.bone.2019.02.025_bb0030","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.bone.2015.02.022","article-title":"Hypophosphatasia: validation and expansion of the clinical nosology for children from 25 years experience with 173 pediatric patients","volume":"75","author":"Whyte","year":"2015","journal-title":"Bone"},{"key":"10.1016\/j.bone.2019.02.025_bb0035","series-title":"Online Mendelian Inheritance in Man, OMIM\u00ae","year":"2019"},{"key":"10.1016\/j.bone.2019.02.025_bb0040","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1161\/CIRCRESAHA.111.247965","article-title":"Genetics in arterial calcification: pieces of a puzzle and cogs in a wheel","volume":"109","author":"Rutsch","year":"2011","journal-title":"Circ. Res."},{"key":"10.1016\/j.bone.2019.02.025_bb0045","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/jbmr.1752","article-title":"Severe skeletal toxicity from protracted etidronate therapy for generalized arterial calcification of infancy","volume":"28","author":"Otero","year":"2013","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2019.02.025_bb0050","series-title":"Strensiq [package insert]","year":"2016"},{"key":"10.1016\/j.bone.2019.02.025_bb0055","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/jbmr.3075","article-title":"Hypophosphatasia: enzyme replacement therapy bring new opportunities and new challenges","volume":"32","author":"Whyte","year":"2017","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2019.02.025_bb0060","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1056\/NEJMoa1106173","article-title":"Enzyme replacement therapy in life-threatening hypophosphatasia","volume":"366","author":"Whyte","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2019.02.025_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/jci.insight.85971","article-title":"Asfotase alfa therapy for children with hypophosphatasia","volume":"1","author":"Whyte","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.bone.2019.02.025_bb0070","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.bone.2018.12.011","article-title":"Five-year efficacy and safety of asfotase alfa for adults and adolescents with hypophosphatasia","volume":"121","author":"Kishnani","year":"2019","journal-title":"Bone"},{"key":"10.1016\/j.bone.2019.02.025_bb0075","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S2213-8587(18)30307-3","article-title":"Asfotase alfa for infants and young children with hypophosphatasia: 7 year outcomes of a single-arm, open-label, phase 2 extension trial","volume":"7","author":"Whyte","year":"2019","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.bone.2019.02.025_bb0080","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1161\/hc4601.099464","article-title":"Coronary artery calcification in older adults to age 99 prevalence and risk factors","volume":"104","author":"Newman","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.bone.2019.02.025_bb0085","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1172\/JCI117814","article-title":"Alkaline phosphatase: placental and tissue nonspecific isoenzymes hydrolyze phospho-ethanolamine, inorganic pyrophosphate, and pyridoxal 5\/-phosphate (substrate accumulation in carriers of hypophosphatasia corrects during pregnancy)","volume":"95","author":"Whyte","year":"1995","journal-title":"J. Clin. Investig."},{"issue":"Suppl. 1","key":"10.1016\/j.bone.2019.02.025_bb0090","first-page":"SA413","article-title":"Hypophosphatasia: c.1133A>T, p.D378V is the most common American TNSALP mutation (abstract)","volume":"19","author":"Mumm","year":"2006","journal-title":"J. Bone Miner. Res."},{"issue":"7","key":"10.1016\/j.bone.2019.02.025_bb0095","doi-asserted-by":"crossref","first-page":"981","DOI":"10.2106\/00004623-198668070-00004","article-title":"Management of femoral fractures and pseudofractures in adult hypophosphatasia","volume":"68","author":"Coe","year":"1986","journal-title":"J. Bone Joint Surg. Am."},{"key":"10.1016\/j.bone.2019.02.025_bb0100","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1002\/jbmr.1565","article-title":"\u201cAtypical femoral fractures\u201d during bisphosphonate exposure in adult hypophosphatasia","volume":"27","author":"Sutton","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2019.02.025_bb0105","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.amjcard.2008.08.032","article-title":"Relation of serum fetuin-A levels to coronary artery calcium in African-American patients on chronic hemodialysis","volume":"103","author":"Zheng","year":"2009","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.bone.2019.02.025_bb0110","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1148\/radiol.2432050808","article-title":"Coronary artery calcium: a multi-institutional, multimanufacturer international standard for quantification at cardiac CT","volume":"243","author":"McCollough","year":"2007","journal-title":"Radiology"},{"key":"10.1016\/j.bone.2019.02.025_bb0115","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jcct.2009.10.002","article-title":"Coronary artery calcium scoring using a reduced tube voltage and radiation dose protocol with dual-source computed tomography","volume":"3","author":"Nakazato","year":"2009","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"10.1016\/j.bone.2019.02.025_bb0120","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0735-1097(90)90282-T","article-title":"Quantification of coronary artery calcium using ultrafast computed tomography","volume":"15","author":"Agatston","year":"1990","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bone.2019.02.025_bb0125","series-title":"Coronary Radiology","first-page":"223","article-title":"Non-invasive measurement of the coronary atherosclerosis. Measuring coronary calcium","author":"Groen","year":"2009"},{"key":"10.1016\/j.bone.2019.02.025_bb0130","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/jbmr.3405","article-title":"Long-term atherosclerotic vascular disease risk and prognosis in elderly women with abdominal aortic calcification on lateral spine images captured during bone density testing: a prospective study","volume":"33","author":"Lewis","year":"2018","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2019.02.025_bb0135","doi-asserted-by":"crossref","DOI":"10.2217\/bmm-2018-0089","article-title":"Circulating bone-specific alkaline phosphatase and abdominal aortic calcification in maintenance hemodialysis patients","author":"Yan","year":"2018","journal-title":"Biomark. Med"},{"key":"10.1016\/j.bone.2019.02.025_bb0140","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1002\/jcp.26166","article-title":"Inhibition of arterial medial calcification and bone mineralization by extracellular nucleotides: the same functional effect mediated by different cellular mechanisms","volume":"233","author":"Patel","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bone.2019.02.025_bb0145","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1093\/eurheartj\/ehu163","article-title":"Medial vascular calcification revisited: review and perspectives","volume":"35","author":"Lanzer","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bone.2019.02.025_bb0150","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/nrcardio.2010.115","article-title":"Regulatory mechanisms in vascular calcification","volume":"7","author":"Sage","year":"2010","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.bone.2019.02.025_bb0155","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.tcm.2012.07.009","article-title":"Calcium regulaton of vascular smooth muscle cell-derived matrix vesicles","volume":"22","author":"Kapustin","year":"2012","journal-title":"Trends in Cardiovascular Medicine"},{"key":"10.1016\/j.bone.2019.02.025_bb0160","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1161\/01.RES.87.11.1055","article-title":"Apoptosis regulates human vascular calcification in vitro: evidence for initiation of vascular calcification by apoptotic bodies","volume":"87","author":"Proudfoot","year":"2000","journal-title":"Circ. Res."},{"key":"10.1016\/j.bone.2019.02.025_bb0165","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.bone.2017.07.006","article-title":"Vascular ossification: pathology, mechanisms, and clinical implications","volume":"109","author":"Fuery","year":"2018","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.bone.2019.02.025_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0003-9861(84)90356-4","article-title":"Can biological calcification occur in the presence of pyrophosphate?","volume":"231","author":"Meyer","year":"1984","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bone.2019.02.025_bb0175","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1253\/circj.CJ-11-0477","article-title":"Calcium phosphate deposition with normal phosphate concentration. Role of pyrophosphate","volume":"75","author":"Villa-Bellosta","year":"2011","journal-title":"Circ. J."},{"key":"10.1016\/j.bone.2019.02.025_bb0180","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1007\/s00198-017-4035-y","article-title":"Mutational and biochemical findings in adults with persistent hypophosphatasemia","volume":"28","author":"McKiernan","year":"2017","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2019.02.025_bb0185","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/jbmr.2110","article-title":"Calcific periarthritis as the only clinical manifestation of hypophosphatasia in middle-aged sisters","volume":"29","author":"Gua\u00f1abens","year":"2014","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2019.02.025_bb0190","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1001\/archopht.1964.00970010513011","article-title":"Band keratopathy and conjunctival calcification in hypophosphatasia","volume":"71","author":"Lessell","year":"1964","journal-title":"Arch. Ophthalmol."},{"issue":"Suppl. 1","key":"10.1016\/j.bone.2019.02.025_bb0195","first-page":"306","article-title":"Hyperphosphatemia in hypophosphatasia of childhood is associated with decreased FGF7 and normal FGF23 levels in the circulation (abstract)","volume":"33","author":"Whyte","year":"2018","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2019.02.025_bb0200","doi-asserted-by":"crossref","first-page":"4606","DOI":"10.1210\/jc.2013-1811","article-title":"Acute severe hypercalcemia after traumatic fractures and immobilization in hypophosphatasia complicated by chronic renal failure","volume":"98","author":"Whyte","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2019.02.025_bb0205","series-title":"Alkaline Phosphatase","author":"McComb","year":"1979"},{"key":"10.1016\/j.bone.2019.02.025_bb0210","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1016\/j.jacc.2017.02.030","article-title":"ANGPTL3 deficiency and protection against coronary artery disease","volume":"69","author":"Stitziel","year":"2017","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328219300766?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328219300766?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,24]],"date-time":"2019-10-24T14:48:52Z","timestamp":1571928532000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328219300766"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":42,"alternative-id":["S8756328219300766"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2019.02.025","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"No vascular calcification on cardiac computed tomography spanning asfotase alfa treatment for an elderly woman with hypophosphatasia","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2019.02.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}